Elmind Capital, LP - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Elmind Capital, LP held in its portfolio 34 assets valued at $338,852,146 (i.e. $338.85M).
The most valuable assets in the portfolio included: COGENT BIOSCIENCES INC ($41.59M), SYNDAX PHARMACEUTICALS INC ($38.97M), and VIRIDIAN THERAPEUTICS INC ($26.72M).
The chart below shows the top 10 valuable assets, and the table below shows the top 34 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Elmind Capital, LP - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| COGENT BIOSCIENCES INC | 1170740 | 41584685 | COM |
| SYNDAX PHARMACEUTICALS INC | 1855000 | 38973550 | COM |
| VIRIDIAN THERAPEUTICS INC | 858631 | 26720597 | COM |
| VERA THERAPEUTICS INC | 482500 | 24433800 | CL A |
| CELLDEX THERAPEUTICS INC NEW | 865000 | 23493400 | COM NEW |
| CG ONCOLOGY INC | 492500 | 20448600 | COM |
| BIOCRYST PHARMACEUTICALS INC | 2150000 | 16770000 | COM |
| VAXCYTE INC | 291500 | 13449810 | COM |
| BEAM THERAPEUTICS INC | 476338 | 13204089 | COM |
| PHARVARIS N V | 475750 | 13202063 | COM |
| KALVISTA PHARMACEUTICALS INC | 801300 | 12940995 | COM |
| DYNAVAX TECHNOLOGIES CORP | 679900 | 10456862 | COM NEW |
| TYRA BIOSCIENCES INC | 350000 | 9201500 | COM |
| NURIX THERAPEUTICS INC | 460000 | 8726200 | COM |
| WAVE LIFE SCIENCES LTD | 447846 | 7613382 | SHS |
| MBX BIOSCIENCES INC | 211000 | 6654940 | COM |
| KRYSTAL BIOTECH INC | 22000 | 5423880 | COM |
| UNITED THERAPEUTICS CORP DEL | 11000 | 5359750 | COM |
| BIOMARIN PHARMACEUTICAL INC | 82000 | 4873260 | COM |
| RELAY THERAPEUTICS INC | 536946 | 4542563 | COM |
| TRAVERE THERAPEUTICS INC | 110000 | 4203100 | COM |
| PROTAGONIST THERAPEUTICS INC | 38000 | 3318920 | COM |
| CULLINAN THERAPEUTICS INC | 310000 | 3208500 | COM |
| LIQUIDIA CORPORATION | 90000 | 3104100 | COM NEW |
| CYTOMX THERAPEUTICS INC | 700000 | 2982000 | COM |
| UROGEN PHARMA LTD | 100000 | 2342000 | COM |
| IMMUNOCORE HLDGS PLC | 58248 | 2021788 | ADS |
| DESIGN THERAPEUTICS INC | 207900 | 1950102 | COM |
| ENGENE HOLDINGS INC | 210000 | 1896300 | COM |
| ALECTOR INC | 900000 | 1404000 | COM |
| AMYLYX PHARMACEUTICALS INC | 112000 | 1352960 | COM |
| APELLIS PHARMACEUTICALS INC | 50000 | 1256000 | COM |
| SUPERNUS PHARMACEUTICALS INC | 20000 | 994000 | COM |
| EDGEWISE THERAPEUTICS INC | 30000 | 744450 | COM |